Sign in

CIK 0001438533

  • Large accelerated filer

Travere Therapeutics, Inc.

Sign in to watch
Ticker
TVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
262383102
Phone
+1 888-969-7879
Business address
3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
Former names
Retrophin, Inc., Desert Gateway, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$79,495,607
in 10 filings, $79.5M under 10b5-1 plans

Net −$79,495,607. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 20 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-05-09 Meckler Jeffrey A Director Grant or award +2,500 59,000
2018-05-09 Meckler Jeffrey A Director Grant or award · Employee Stock Option (Right to Buy) +10,000 10,000
2018-03-07 ASELAGE STEVE Chief Executive Officer Exercise or conversion +278 $6.00 $2K 221,383
2018-03-07 ASELAGE STEVE Chief Executive Officer Exercise or conversion · Common Stock Purchase Warrants −278 0
2018-02-14 ROTE WILLIAM E. Senior Vice President, R&D Sale −1,034 $21.50 $22K 11,156
2018-02-08 REED ELIZABETH E SVP, GC & Corporate Secretary Grant or award +1,769 10,827
2018-02-08 ROTE WILLIAM E. Senior Vice President, R&D Grant or award +1,985 12,190
2018-02-08 Clague Laura Chief Financial Officer Grant or award +2,033 2,033
2018-02-08 McFarlane Neil F. Chief Operating Officer Grant or award +2,546 17,448
2018-02-08 ASELAGE STEVE Chief Executive Officer Grant or award +3,549 221,105
2018-01-05 REED ELIZABETH E SVP, GC & Corporate Secretary Sale −942 $24.04 $23K 9,058
2017-12-26 ASELAGE STEVE Chief Executive Officer Gift −23,000 217,556
2017-12-21 ASELAGE STEVE Chief Executive Officer Gift −5,000 240,556
2017-08-16 McFarlane Neil F. Chief Operating Officer Sale −1,378 $22.50 $31K 13,622
2017-06-14 ASELAGE STEVE Chief Executive Officer Purchase −5,000 $17.85 $89K 245,556
2017-05-17 KOZARICH JOHN W Director Grant or award +2,500 24,500
2017-05-17 KOZARICH JOHN W Director Grant or award · Employee Stock Option (Right to Buy) +10,000 10,000
2017-05-17 LYONS GARY A Director Grant or award +2,500 26,500
2017-05-17 LYONS GARY A Director Grant or award · Employee Stock Option (Right to Buy) +10,000 10,000
2017-05-17 Meckler Jeffrey A Director Grant or award +2,500 56,500

Page 52 of 59 · 1,174 trades